🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates whether it is safe to administer a peptide vaccine wit...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-04
Trial ID
NCT02385669
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine in ...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-05-12
Trial ID
NCT02425306
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine (6M...
Status
Completed
Location
University of Virginia
Start Date
2018-11-13
Trial ID
NCT03617328
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
University of Virginia Cancer Center
Start Date
2003-07
Trial ID
NCT00089219
This study evaluates whether it is safe to administer a peptide vaccine in ...
Status
Completed
Location
University of Virginia Cancer Center
Start Date
2016-10-06
Trial ID
NCT02515227
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2005-05-09
Trial ID
NCT00071981
This study evaluates whether it is safe to administer a helper peptide vacc...
Status
Terminated
Location
University of Virginia
Start Date
2016-04
Trial ID
NCT02382549
Treatments Being Tested
This study evaluates whether it is safe to administer a peptide vaccine mad...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Center
Start Date
2020-09-28
Trial ID
NCT04364230
Treatments Being Tested